InsidersTradesSigma
Follow the Dogwood Therapeutics, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €84.6m. The latest transaction was filed on 25 November 2025 (C). Among the most active insiders: Sealbond Ltd. Every trade is accessible without an account.
Analysts rate Dogwood Therapeutics, Inc. Strong Buy (bullish), based on 3 analysts. Average price target: US$14.00.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Dogwood Therapeutics, Inc. is a company focused on developing innovative treatments for neurological diseases. It is listed on the XNAS market.